Medtronic’s SPR Therapeutics deal signals a sharper move into earlier chronic pain intervention
Chronic pain care needs non-opioid options. Medtronic’s SPR Therapeutics deal tests whether temporary PNS can scale beyond niche adoption.
Medical Devices & Diagnostics
Pharma & Biotech
Why Pacira BioSciences, Inc. is positioning EXPAREL as a cost-saving tool in Medicare surgery
Find out how Pacira BioSciences, Inc.’s EXPAREL data could reduce opioid use and surgical costs in Medicare patients.
Pharma & Biotech
Does VAS-101 solve a long-standing delivery problem in curcumin-based osteoarthritis treatment?
Vascarta’s VAS-101 showed early knee osteoarthritis pain benefits. Read what the data changes, what remains unclear, and what to watch next.